2022年1月,細胞治療有關的市場研究報告 “Global Cell Freezing Media for Cell Therapy
Professional Survey Report 2022, Forecast to 2027”已正式發佈,報告用於細胞治療專業市場的整個細胞冷凍培養基的前景,包括全球銷售和收入預測、區域預測。 它還按類型和應用預測了用於細胞治療專業市場的細胞冷凍培養基。
研究報告提及部份出色的行業參與者,如下
* BioLife Solutions
* Thermo Fisher Scientific
* Merck
* GE Healthcare
* Zenoaq
* WAK-Chemie Medical
* Biological Industries
* Akron Biotechnology
是次全面的市場研究報告,相信可以幫助客戶保持更新並在他們的業務中做出有效的決策。
Other news
亞洲最有價值品牌大獎2024
Hong Kong Weike Biotechnology Company Limited was awarded “Most Trusted Biotechnology Solutions Of The Year” of Asia’s
九月
Scientific Annual Report of CELLBANKERs (2023)
・ The number of citations in 2023 was 266 and reached record high. ・The number of
五月
2023年度最傑出生物技術產品
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by
九月
Global Cell Freezing Media for Cell Therapy Professional Survey Report
A report titled, “Global Cell Freezing Media for Cell Therapy Professional Survey Report 2022, Forecast
四月
CELLBANKER’s Scientific Annual Report (2021)
ZENOAQ has issued publications on research of cell cryopreserved regularly. Here is the summary for
二月